ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,165.48
0.74%
Dow Jones
38,810.00
0.35%
US Dollar vs MXN
16.872
-0.66%
Brent Oil
82.98
-0.17%
Bitcoin
63,158.06
-1.31%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. GoodRx Holdings Inc (GDRX)

  7. GoodRx Holdings Inc (GDRX) Noticias

GDRX GoodRx Holdings Inc

7.395
0.295 (4.15%)
Última actualización: 12:53:10
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
GoodRx Holdings Inc GDRX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.295 4.15% 7.395 12:53:10
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
7.25 7.2049 7.48 7.10
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
03/5/202404:45PRNUSClass Action Filed Against GoodRx Holdings, Inc. (GDRX)..
24/4/202407:00BWGoodRx Announces Date for 2024 Investor Day
11/4/202415:09BWGoodRx Announces Date for First Quarter 2024 Earnings..
14/3/202407:00BWGoodRx Interim CEO Extends Commitment to Company
08/3/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202416:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202416:20EDGAR2Form 8-K - Current report
07/3/202406:00EDGAR2Form 8-K - Current report
01/3/202415:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202413:37EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/2/202413:04EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202405:12EDGAR2Form 8-K - Current report
29/2/202405:02BWGoodRx Reports Fourth Quarter and Full Year 2023 Results
20/2/202415:05BWGoodRx to Participate in Upcoming Investor Conferences
08/2/202415:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202415:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202415:05BWGoodRx Announces Date for Fourth Quarter and Full Year 2023..
22/1/202413:15BWGoodRx Announces Proposed Refinancing of First Lien Credit..
17/1/202414:51EDGAR2Form 8-K - Current report
16/1/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202408:00BWThe GoodRx Effect: Delivering a Transformative Impact on the..
10/1/202408:01BWGoodRx Announces Preliminary Fourth Quarter and Full Year..
10/1/202408:00EDGAR2Form 8-K - Current report
22/12/202308:06EDGAR2Form 8-K - Current report
22/12/202308:00BWGoodRx Appoints Kelly J. Kennedy to Board of Directors
13/12/202315:05BWGoodRx to Participate in the 42nd Annual J.P. Morgan..
08/12/202316:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202316:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202314:28EDGAR2Form 8-K - Current report
04/12/202315:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202315:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202315:51EDGAR2Form 8-K - Current report
20/11/202316:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202315:05BWGoodRx to Participate in the Evercore ISI HealthCONx..
09/11/202313:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202305:04EDGAR2Form 8-K - Current report
09/11/202305:02BWGoodRx Reports Third Quarter 2023 Results
08/11/202315:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202315:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/10/202318:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/10/202318:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202308:00BWGoodRx Announces New Way for Consumers to Access Sanofi’s..
17/10/202315:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202315:05BWGoodRx Announces Date for Third Quarter 2023 Earnings..
12/10/202308:00BWGoodRx and Navitus Health Solutions Announce Savings Connect..
21/9/202308:00BW GoodRx Announces Significant Savings on Antivirals,..
13/9/202308:00BWGoodRx and MedImpact Announce Program to Ensure Seamless..
11/9/202308:00BWGoodRx Now Offers 40% More Savings on Nearly 200 Medications..
08/9/202316:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202316:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NASDAQ
GDRX
GoodRx
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados